Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Bio-Solutions (BISU.OB) to Grant Shareholders 1 for 5 Stock Dividend

Bio-Solutions Corporation announced after the closing bell on Friday that they will be granting a one-time one for five stock dividend to their shareholders. For every 5 shares an investor holds, one share will be granted by the company. These shares will be payable on July 1, 2010 to all shareholders as of close of market on the record date of June 29th 2010. The decision to grant the dividend was unanimously agreed upon by the Bio-Solutions directors.

An 8-K filed with the Security and Exchange Commission (SEC) stated, “On June 11, 2010, the Registrant’s board of directors authorized a 1.20 for 1 stock split (“Split”) of the Registrant’s issued and outstanding common stock. The Split will be effectuated through the issuance of 0.20 share for each share of common stock outstanding as of the record date. The record date for the Split is June 29, 2010. The payable date of the Split is July 1, 2010. Prior to the Split, there are 15,059,350 shares issued and outstanding. Following the Split, there will be approximately 18,071,220 shares issued and outstanding. The Registrant’s common stock will continue to be $.001 par value. Fractional shares will be rounded upward. The Registrant’s symbol and CUSIP Number will not change as a result of the Split. In connection with the Split, the Registrant filed a Certificate of Change with the State of Nevada to effect the Split of the Registrant’s authorized and outstanding shares of common stock with an effective date of filing of June 30, 2010. The Certificate of Change provides that the Registrant’s authorized number of shares of common stock increases from 75,000,000 to 90,000,000.”

CEO and President Gilles Chaumillon stated, “This one time stock dividend is a small demonstration of the company’s way of giving back to all of our Loyal Shareholders. We believe our shareholders have been an understanding and patient group of investors while we have continued to implement our business plan. ”

Bio-Solutions has been actively marketing their flagship product, GREENEX™, and their secondary product, NutraAnimal™, worldwide. Negotiations with a variety of African government bodies are ongoing in the countries of Congo, Burkina Faso, Niger and Mali with the anticipation that agreements will be reached in the near future for both of the Bio-Solutions products.

GREENEX, an organic insecticide available in both solid and liquid form, is believed to neutralize and eradicate up to 98% of the mosquito larvae within a 24 hour period. Malaria is a devastating disease that is transmitted by mosquitoes and is prevalent throughout Africa. Bio-Solutions has previously announced Letters of Intent from the Democratic Republic of Congo and Burkina for their GREENEX product. Bio-Solutions has met with local authorities in the Democratic Republic of Congo (NYSE:DRC) and has confirmed a service offer, to run a pilot study of GreenEx™, in Kinshasa Congo. The trial will begin once financing has been secured.

NutraAnimal, a milled supplement composed of active ingredients of organic marine source, has been proven through research to boost poultry growth. Preliminary results have shown that by supplementing the chicken’s diet with NutraAnimal, feed conversion rate was improved by up to 10% with a chicken weight increase of 7%, while decreasing the mortality by more than 50%. On April 30th, Bio-Solutions announced that the North Eastern district of Burkina Faso had retained them as a primary consultant regarding the implementation of the NutraAnimal product line.

More information on Bio-Solutions products and business strategies is available on the company website at

Please see disclaimer on QualityStocks website:

Disclosure: no positions